• / Free eNewsletters & Magazine
  • / My Account

CROs

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Pharm-Olam International Deploys Medidata Rave; Shores up Global Data Management and Reporting Capabilities

    Pharm-Olam International Deploys Medidata Rave; Shores up Global Data Management and Reporting Capabilities

  2. Late-Stage Businesses Drive Narrow Moats for CROs

    The top contract research organizations have opportunities to gain share in a rapidly growing industry.

  3. Signet Accel and ACRES Bring Interoperability to Global Biopharma Clinical Research System

    Signet Accel and ACRES Bring Interoperability to Global Biopharma Clinical Research System

  4. Health Care’s Outlook Clarifies

    Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.

  5. Amid Turmoil, Don’t Discount Foreign Equities

    Use this screen to find overlooked small- and mid-cap international stocks.

  6. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

©2017 Morningstar Advisor. All right reserved.